InsiderClue
Stocks · Health care · Pharmaceutical Preparations

ANI PHARMACEUTICALS INC

ANIP Clue Score55
United States Fiscal year ends December CIK 0001023024 Results filed 5 Nov 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

82
Insider
Date
Role
Action
Shares
Price
Amount
Ori Gutwerg
10 Aug 2026
SVP, Generics
Sell
3,162
$77.00
$243.47K
Patrick D Walsh
13 May 2026
Director
Sell
10,000
$80.63
$806.30K
Ori Gutwerg
12 May 2026
SVP, Generics
Sell
2,772
$79.50
$220.37K
Thomas Andrew Rowland
12 May 2026
SVP, Head - Established Brands
Sell
459
$79.21
$36.36K
Nikhil Lalwani
11 May 2026
President & CEO
Sell
55,000
$77.57
$4.27M
Patrick D Walsh
11 May 2026
Director
Sell
3,973
$80.75
$320.82K
Thomas Andrew Rowland
11 Mar 2026
SVP, Head - Established Brands
Sell
4,772
$74.91
$357.47K
Patrick D Walsh
3 Mar 2026
Director
Sell
6,000
$74.23
$445.38K
Ori Gutwerg
3 Mar 2026
SVP, Generics
Sell
2,060
$76.50
$157.59K
Renee P Tannenbaum
5 Dec 2025
Director
Sell
1,800
$81.15
$146.07K
Chad Gassert
13 Nov 2025
SVP - Corp. Dev. & Strategy
Sell indirect
94
$88.00
$8.27K
Patrick D Walsh
13 Nov 2025
Director
Sell
8,643
$86.88
$750.90K
Chad Gassert
12 Nov 2025
SVP - Corp. Dev. & Strategy
Sell indirect
14,642
$89.07
$1.30M
Antonio R Pera
3 Sep 2025
Director
Sell
7,292
$94.94
$692.30K
Matthew J Leonard
25 Aug 2025
Director
Sell
2,528
$90.62
$229.09K
Krista Davis
22 Aug 2025
SVP, Chief HR Officer
Sell
1,763
$91.10
$160.61K
Muthusamy Shanmugam
21 Aug 2025
Head of R&D, COO-Novitium Ops
Sell indirect
52,988
$90.44
$4.79M
Antonio R Pera
20 Aug 2025
Director
Sell
5,421
$89.73
$486.43K
Muthusamy Shanmugam
20 Aug 2025
Head of R&D, COO-Novitium Ops
Sell indirect
47,012
$90.27
$4.24M
Matthew J Leonard
18 Aug 2025
Director
Sell
6,937
$88.17
$611.64K
Jeanne Thoma
18 Aug 2025
Director
Sell
14,675
$88.87
$1.30M
Jeanne Thoma
18 Aug 2025
Director
Sell
6,865
$89.76
$616.20K
Chad Gassert
15 Aug 2025
SVP - Corp. Dev. & Strategy
Sell indirect
20,000
$86.97
$1.74M
Muthusamy Shanmugam
15 Aug 2025
Head of R&D, COO-Novitium Ops
Sell indirect
52,990
$87.15
$4.62M
Patrick D Walsh
15 Aug 2025
Director
Sell
9,000
$89.05
$801.45K
Muthusamy Shanmugam
14 Aug 2025
Head of R&D, COO-Novitium Ops
Sell indirect
47,010
$89.48
$4.21M
Thomas Haughey
12 Aug 2025
Director
Sell
19,341
$85.93
$1.66M
Ori Gutwerg
12 Aug 2025
SVP, Generics
Sell
5,873
$86.53
$508.19K
Nikhil Lalwani
12 Aug 2025
President & CEO
Sell
56,960
$85.93
$4.89M
Thomas Andrew Rowland
12 Aug 2025
SVP, Head - Established Brands
Sell
4,975
$85.71
$426.41K
Ori Gutwerg
15 May 2025
SVP, Generics
Sell
881
$60.07
$52.92K
Christopher Mutz
14 May 2025
Head of Rare Disease
Sell
4,000
$60.45
$241.80K
Stephen P. Carey
17 Dec 2024
SVP & CFO
Sell
7,500
$55.79
$418.43K
Christopher Mutz
15 Nov 2024
Head of Rare Disease
Sell
6,500
$57.70
$375.05K
Ori Gutwerg
5 Jun 2024
SVP, Generics
Sell
2,985
$67.00
$200.00K
Stephen P. Carey
4 Jun 2024
SVP & CFO
Sell
5,000
$63.58
$317.90K
Christopher Mutz
21 May 2024
Head of Rare Disease
Sell
2,000
$61.61
$123.22K
Renee P Tannenbaum
16 May 2024
Director
Sell
2,000
$63.87
$127.74K
Nikhil Lalwani
14 May 2024
President & CEO
Sell
16,669
$66.10
$1.10M
Stephen P. Carey
11 Mar 2024
SVP & CFO
Sell
7,787
$65.55
$510.44K
Nikhil Lalwani
8 Mar 2024
President & CEO
Sell
16,292
$67.13
$1.09M
James G. Marken
7 Mar 2024
SVP Ops & Prod Dev
Sell
24,338
$66.37
$1.62M
Nikhil Lalwani
6 Mar 2024
President & CEO
Sell
28,965
$65.52
$1.90M
Christopher Mutz
5 Mar 2024
Head of Rare Disease
Sell
5,000
$66.00
$330.00K
Antonio R Pera
4 Mar 2024
Director
Sell
7,000
$65.20
$456.40K
Krista Davis
15 Nov 2023
SVP, Chief HR Officer
Sell
2,622
$53.81
$141.09K
Christopher Mutz
10 Nov 2023
Head of Rare Disease
Sell
3,000
$52.47
$157.41K
Muthusamy Shanmugam
29 Aug 2023
Head of R&D, COO-Novitium Ops
Sell indirect
25,000
$63.37
$1.58M
Muthusamy Shanmugam
28 Aug 2023
Head of R&D, COO-Novitium Ops
Sell indirect
25,000
$63.06
$1.58M
Meridian Venture Partners II LP
16 Aug 2023
10% owner
Sell
200,000
$58.50
$11.70M
Stephen P. Carey
14 Aug 2023
SVP & CFO
Sell
17,639
$61.37
$1.08M
Nikhil Lalwani
11 Aug 2023
President & CEO
Sell
56,666
$57.75
$3.27M
Meridian Venture Partners II LP
1 Dec 2022
10% owner
Sell
200,000
$38.50
$7.70M
James G. Marken
15 Aug 2022
SVP Ops & Prod Dev
Sell
5,172
$37.79
$195.46K
James G. Marken
12 Aug 2022
SVP Ops & Prod Dev
Sell
12,894
$37.04
$477.61K
Meridian Venture Partners II LP
20 Aug 2019
10% owner
Sell
5,512
$68.18
$375.81K
Meridian Venture Partners II LP
19 Aug 2019
10% owner
Sell
2,067
$68.30
$141.18K
Meridian Venture Partners II LP
16 Aug 2019
10% owner
Sell
26,349
$68.09
$1.79M
Meridian Venture Partners II LP
15 Aug 2019
10% owner
Sell
9,315
$69.34
$645.90K
Meridian Venture Partners II LP
14 Aug 2019
10% owner
Sell
26,360
$69.89
$1.84M
Meridian Venture Partners II LP
13 Aug 2019
10% owner
Sell
20,821
$71.77
$1.49M
Meridian Venture Partners II LP
12 Aug 2019
10% owner
Sell
21,016
$71.45
$1.50M
Meridian Venture Partners II LP
9 Aug 2019
10% owner
Sell
19,860
$71.70
$1.42M
James G. Marken
17 May 2019
SVP Ops & Prod Dev
Sell
8,907
$70.67
$629.46K
Arthur Przybyl
15 May 2019
President and CEO
Sell
14,633
$69.25
$1.01M
James G. Marken
14 May 2019
SVP Ops & Prod Dev
Sell
4,917
$70.31
$345.71K
Arthur Przybyl
14 May 2019
President and CEO
Sell
5,772
$70.45
$406.64K
Robert W Schrepfer
13 May 2019
SVP - New Bus Dev & Spec Sales
Sell
2,409
$71.13
$171.35K
Arthur Przybyl
13 May 2019
President and CEO
Sell
9,595
$71.10
$682.20K
Tracy Marshbanks
16 May 2018
Director
Sell indirect
25,706
$62.40
$1.60M
Tracy Marshbanks
15 May 2018
Director
Sell indirect
7,024
$62.05
$435.84K
Tracy Marshbanks
14 May 2018
Director
Sell indirect
5,506
$62.35
$343.30K
Tracy Marshbanks
10 May 2018
Director
Sell indirect
24,229
$62.03
$1.50M
Tracy Marshbanks
10 May 2018
Director
Sell indirect
17,685
$62.14
$1.10M
Tracy Marshbanks
9 May 2018
Director
Sell indirect
20,517
$62.05
$1.27M
Tracy Marshbanks
18 Apr 2018
Director
Sell indirect
33,200
$62.09
$2.06M
Daniel Raynor
19 Mar 2018
Director
Sell indirect
5,313
$60.62
$322.07K
Daniel Raynor
15 Mar 2018
Director
Sell indirect
1,902
$61.50
$116.97K
Daniel Raynor
14 Mar 2018
Director
Sell indirect
1,919
$62.02
$119.02K
Arthur Przybyl
14 Mar 2018
President and CEO
Sell
10,000
$62.03
$620.30K
Tracy Marshbanks
14 Mar 2018
Director
Sell indirect
1,912
$63.10
$120.65K
Daniel Raynor
13 Mar 2018
Director
Sell indirect
4,117
$62.59
$257.68K
Showing 250 of 268 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 443
Amendments (4/A) skipped 3
Filings about a different issuer 0
Unreadable filings 0
Joint filings 5
Sales on a Rule 10b5-1 plan 127
Sales straight out of an exercise 26
Sales at will 89
Transactions with no price 0
Shares from compensation/vesting 4,962,594
Sales filed before the plan box existed 37
History held since 29 Sep 2006